Boehringer Ingelheim University of Dundee extend anticancer alliance

Boehringer Ingelheim, University of Dundee extend anti-cancer alliance

07:00 EDT 12 Jun 2019 | Pharmaceutical Business Review

This brings together the expertise of Professor Alessio Ciulli, one of the pioneers in the field of Proteolysis targeting chimeras (PROTACs), based in the School of Life Sciences

The post Boehringer Ingelheim, University of Dundee extend anti-cancer alliance appeared first on Pharmaceutical Business review.

Original Article: Boehringer Ingelheim, University of Dundee extend anti-cancer alliance

More From BioPortfolio on "Boehringer Ingelheim, University of Dundee extend anti-cancer alliance"